Stomach cancer is a life-threatening diagnosis, but stomach dysplasia is a precancerous condition that may not be as serious. Read on for details…
The older you are, the more likely breast cancer is due to what you eat and do, not your genes. You can reduce your risk!
If you’re at high risk for breast cancer and are considering a mastectomy, read this first.
Still expecting a Pap test at your ob/gyn visits? Here’s why the new first-line test is better.
How quickly you complete all parts of your treatment makes a big difference in how effective it is.
A diet rich in omega-3 fatty acids may reduce inflammation and help keep this cancer from spreading.
Yes, there’s a test to find cancer early. So why aren’t there screening guidelines for women at risk?
The care of thousands of women doesn’t follow the recommended imaging guidelines. Don’t be one of them.
Worrying about cancer coming back after treatment is normal, but for some people the worry becomes incapacitating. Don’t let that happen to you…
A new study connects the dots between a relatively common medical condition and pancreatic cancer.
YouTube videos often give biased and/or misleading information about prostate cancer screening and treatment. Here’s how to find reliable videos…
While many other cancers are decreasing, uterine cancer (aka endometrial cancer) is increasing. But there are ways to protect yourself.
Colonoscopy may be the gold standard for detecting precancerous polyps, but there are less-invasive options for those who just won’t have the test.
The gut “microbiome” is known to affect digestive health and risk for chronic diseases. But new research shows it also affects the breasts. Here’s how…
You know getting screened for colon cancer could save your life, but the test is such a hassle. Get over it!
Yes, basal cell skin cancers are very common and treatable, but we’re learning that they can be a warning for other, more dangerous types of cancer.
Does consuming fewer pesticides truly matter? Now a French study connects the dots to fewer cases of cancer.
Oncologist Pamela Munster often must give unsettling test results to her patients. Then one day her own test came back positive.
The FDA has just rushed approval of a new cancer drug developed not to treat cancer by its location, but to target a specific genetic defect.